bispecific antibodies in b-all; blinatumomab
Published 5 years ago • 253 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
2:25
advancements and challenges in bispecific antibodies for the treatment of b-nhl
-
1:30
bispecific antibodies for r/r aggressive b-cell lymphomas
-
2:38
approaching the treatment of patients with lbcl who relapse after bispecific antibodies
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
37:59
blinatumomab
-
47:35
top doctor & patient talk game changing cancer treatments: how close is a cure? (multiple myeloma)
-
20:53
newest immunotherapies for blood cancer! what to know about bispecifics & car t-cell therapy
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
1:47
the role of blinatumomab in all
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:56
the future of bispecific antibodies in the treatment and management of r/r follicular lymphoma
-
1:15
the role of bispecific antibodies in the treatment of r/r large b-cell lymphoma
-
2:39
the role of bispecific antibodies in the treatment landscape for r/r dlbcl
-
1:17
the promise of bispecific antibodies in the treatment of nhl
-
2:17
the role of car t-cell therapy for treating myeloma in the era of bispecific antibodies
-
4:15
bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab
-
5:47
hovon146all: blinatumomab added to prephase and consolidation therapy in precursor b-all
-
2:22
outcomes and management of patients with r/r myeloma who progress on bispecific antibodies
-
2:43
bispecific antibodies for non-hodgkin lymphoma
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
2:57
the addition of blinatumomab to prephase and consolidation therapy in adult b-all